Literature DB >> 1335975

Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980.

J B Young1, I A Macdonald.   

Abstract

Alterations in sympathetic nervous system (SNS) activity are widely believed to contribute to the pathophysiology of the obese state. Disagreement, however, exists as to whether the predominant sympathetic abnormality is a decrease in neuronal activity (leading to diminished sympathetically-mediated energy expenditure and weight gain) or an increase (leading to hypertension). Findings summarized from over 40 separate studies support both hypotheses as well as the alternative thesis that SNS activity does not differ in obese humans compared to lean controls. Another abnormality being noted with increasing frequency in human obesity is reduced adrenaline (Ad) levels in plasma, both at rest or in response to a stimulus such as physical activity. Whether diminished adrenal medullary function is a cause or consequence of the obese state and whether the adrenal medulla plays any role in the regulation of energy metabolism on a daily basis are not known at the present time. Thus, while depressed SNS activity may be a sufficient explanation for the development of obesity, it is not a necessary condition. Suppressed adrenal medullary function may also contribute to this disorder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335975

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  26 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Obesity and autonomic function.

Authors:  S D Beske; J A Taylor
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 3.  The role of the sympathetic nervous system in linking obesity with hypertension in white versus black Americans.

Authors:  Pirooz Eslami; Michael Tuck
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 4.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 5.  A sympathetic view of human obesity.

Authors:  Elisabeth A Lambert; Nora E Straznicky; Gavin W Lambert
Journal:  Clin Auton Res       Date:  2012-06-21       Impact factor: 4.435

6.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 7.  Body fat and sympathetic nerve activity.

Authors:  U Scherrer; R Owlya; M Lepori
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

8.  Heart rate variability in childhood obesity.

Authors:  G Martini; P Riva; F Rabbia; V Molini; G B Ferrero; F Cerutti; R Carra; F Veglio
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 9.  Neural mechanisms and management of obesity-related hypertension.

Authors:  Murray D Esler; Nina Eikelis; Elisabeth Lambert; Nora Straznicky
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

10.  Daily variations in catecholamine excretion are not influenced by very low calorie diet in obese women.

Authors:  G Del Rio; A Velardo; G Zizzo; S Galetti; P Marrama; L Della Casa
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.